This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5mg | $150 | 3-6 Days |
10mg | $250 | 3-6 Days |
25mg | $450 | 3-6 Days |
50mg | $750 | 3-6 Days |
100mg | $1250 | 3-6 Days |
250mg | $2150 | 3-6 Days |
Cat #: V6047 CAS #: 860005-21-6 Purity ≥ 99%
Description: Latanoprostene (PF3187207; Latanoprostene BUNOD; LBN; BOL-303259-X; NCX116; Vesneo; Vyzulta) is a novel and potent nitric oxide (NO)-donating FP receptor (Prostaglandin F2α receptor) agonist with prostaglandin activity. It loweres intraocular pressure (IOP) more effectively than latanoprost in monkeys, dogs and rabbits. Latanoprostene was approved for use as an ophthalmic drug in the United States in 2017 for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It targets the trabecular meshwork directly.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 507.62 |
---|---|
Molecular Formula | C27H41NO8 |
CAS No. | 860005-21-6 |
SMILES Code | O=C(OCCCCO[N+]([O-])=O)CCC/C=CC[C@@H]1[C@@H](CC[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@@H]1O |
Synonyms | PF-3187207; NCX116; PF3187207; NCX-116; PF 3187207; Latanoprostene BUNOD; BOL-303259-X; NCX116; Vesneo; Vyzulta |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.9700 mL | 9.8499 mL | 19.6998 mL | 39.3996 mL |
5mM | 0.3940 mL | 1.9700 mL | 3.9400 mL | 7.8799 mL |
10mM | 0.1970 mL | 0.9850 mL | 1.9700 mL | 3.9400 mL |
20mM | 0.0985 mL | 0.4925 mL | 0.9850 mL | 1.9700 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.